Suzanne Tavitian

Suzanne Tavitian

UNVERIFIED PROFILE

Are you Suzanne Tavitian?   Register this Author

Register author
Suzanne Tavitian

Suzanne Tavitian

Publications by authors named "Suzanne Tavitian"

Are you Suzanne Tavitian?   Register this Author

27Publications

1143Reads

50Profile Views

More than ten percent of relapses occur after five years in AML patients with mutation.

Leuk Lymphoma 2020 Feb 5:1-4. Epub 2020 Feb 5.

Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1706733DOI Listing
February 2020

Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients.

Open Forum Infect Dis 2019 Sep 28;6(9):ofz345. Epub 2019 Jul 28.

Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofz345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798245PMC
September 2019

Outcome of patients aged 60-75 years with newly diagnosed secondary acute myeloid leukemia: A single-institution experience.

Cancer Med 2019 Jul 7;8(8):3846-3854. Epub 2019 Jun 7.

Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639188PMC
July 2019

Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors.

Leuk Res 2019 Jun 27;81:82-87. Epub 2019 Apr 27.

Université Toulouse III Paul Sabatier, Toulouse, France; Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.04.010DOI Listing
June 2019

Hydroxyurea prior to intensive chemotherapy in AML with moderate leukocytosis.

Leuk Res 2018 12 31;75:7-10. Epub 2018 Oct 31.

Service d'Hématologie, CHU de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; Université Toulouse III Paul Sabatier, Toulouse, France; Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01452126183045
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2018.10.015DOI Listing
December 2018

Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.

Am J Hematol 2018 05 14;93(5):635-642. Epub 2018 Feb 14.

Service Hématologie Greffe, Centre de Référence Aplasies Médullaires Acquises et Constitutionnelles, Université Paris Diderot, Sorbonne Paris Cité, Inserm UMR 1160, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25050DOI Listing
May 2018

Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.

Am J Hematol 2018 03 6;93(3):356-362. Epub 2017 Dec 6.

Département de Néphrologie et Transplantation d'organes, Centre Hospitalier Universitaire de Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24984DOI Listing
March 2018

Improved outcome for AML patients over the years 2000-2014.

Blood Cancer J 2017 11 29;7(12):635. Epub 2017 Nov 29.

Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-017-0011-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802565PMC
November 2017

Asymptomatic circulating T-cell clone cause renal polymorphic inflammatory fibrosis.

Clin Exp Nephrol 2017 Oct 26;21(5):781-786. Epub 2016 Dec 26.

Département de Néphrologie et Transplantation d'organes et Centre de référence des maladies rénales rares, CHU Rangueil, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10157-016-1373-6DOI Listing
October 2017

Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy.

Leuk Res 2017 10 30;61:62-67. Epub 2017 Aug 30.

Université Toulouse III Paul Sabatier, Toulouse, France; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France; Centre de Recherches en Cancérologie de Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.08.015DOI Listing
October 2017

Emerging biological therapies to treat acute lymphoblastic leukemia.

Expert Opin Emerg Drugs 2017 03 25;22(1):107-121. Epub 2016 Dec 25.

a Hematology , University Cancer Institute , Toulouse , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2016.1257606DOI Listing
March 2017

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies.

Oncotarget 2016 Dec;7(52):85937-85947

Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13262DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349887PMC
December 2016

Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response.

Medicine (Baltimore) 2016 Nov;95(48):e5356

aService d'Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole bUniversité Toulouse III Paul Sabatier cService d'Epidémiologie, Centre Hospitalier Universitaire de Toulouse dUMR 1027, INSERM-Université de Toulouse III eService d'Immunologie, Centre Hospitalier de Toulouse Rangueil fService de Virologie, Centre Hospitalier de Toulouse Purpan gUMR 1037, Centre de Recherche en Cancérologie de Toulouse, INSERM-Université de Toulouse III, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134805PMC
November 2016

Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy.

Am J Hematol 2016 Feb 26;91(2):193-8. Epub 2015 Nov 26.

Service d'hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24228DOI Listing
February 2016

Hepatitis E virus excretion can be prolonged in patients with hematological malignancies.

J Clin Virol 2010 Oct 1;49(2):141-4. Epub 2010 Aug 1.

Service d'Hématologie, CHU de Toulouse, Hôpital Purpan, Place du Dr Baylac, 31059 Toulouse cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2010.06.016DOI Listing
October 2010